1)Goh P.
Radiofrequency ablation of lung tumours.
Biomed Imaging Interv J.
2006; 2:e39.
2)Galbis-Caravajal JM,
Pallardó-Calatayud Y,
Revert-Ventura A,
Sales-Badía JG,
Esturi-Navarro R,
Cuenca-Torres M.
Ablación mediante radiofrecuencia guiada por tomografía computarizada de las lesiones pulmonares malignas: experiencia inicial.
Arch Bronconeumol.
2008; 44:364-70.
3) Jin GY,
Lee JM,
Lee YC,
Han YM,
Lim YS.
Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT.
AJR Am J Roentgenol.
2004; 183:1013-20.
4)Steinke K,
King J,
Glenn DW,
Morris DL.
Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience.
AJR Am J Roentgenol.
2004; 183:605-11.
5)Simon CJ,
Dupuy DE,
DiPetrillo TA,
Safran HP,
Grieco CA,
Ng T,
et al.
Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Radiology.
2007; 243:268-75.
6)Alexander ES,
Machan JT,
Ng T,
Breen LD,
Dipetrillo TA,
Dupuy DE.
Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? J Vasc Interv Radiol.
2013; 24:476-82.
7)Gillams A,
Khan Z,
Osborn P,
Lees W.
Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases.
Cardiovasc Intervent Radiol.
2012; 36: 724-30.
8)The Royal College of Radiologists.
Standards for radiofrequecy ablation (RFA).
London: The Royal College of Radiologists. http://www.rcr.ac.uk/404error.aspx?docs/radiology/pdf/BFCR(09)12_Stand_RFA.pdf.
Acceso el 10/10/13.
9)Marco conceptual de la clasificación internacional paran la seguridad del paciente,
versión 1.1.
Informe técnico definitivo.
Organización Mundial de la salud,
2009. www.who.int/patientsafety/ implementation/icps/icps full report es.pdf.
Acceso el 10/8/2012.
10)Sharma A,
Abtin F,
Shepard JA.
Image-guided ablative therapies for lung cancer.
Radiol Clin North Am.
2012; 50:975-99.
11)Abtin FG,
Eradat J,
Gutierrez AJ,
Lee C,
Fishbein MC,
Suh RD.
Radiofrequency ablation of lung tumors: imaging features of the postablation zone.
Radiographics.
2012; 32:947-69.
12)Vogl TJ,
Naguib NN,
Lehnert T,
Nour-Eldin NE.
Radiofrequency,
microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations-review article.
Eur J Radiol.
2011; 77:346-57.
13) Sociedad española de oncología quirúrgica.
Vía clínica para la aplicación de radiofrecuencia en los tumores pulmonares malignos mediante tomografía computerizada.
http://www.seoq.org/descargas/radiofrecuencia_tumores.pdf.
Acceso el 01-03-2013.
14)Manhire A,
Charig M,
Clelland C,
Gleeson F,
Miller R,
Moss H,
et al.
Guidelines for radiologically guided lung biopsy.
Thorax.
2003; 58:920-36.
15) Sonntag PD,
Hinshaw JL,
Lubner MG,
Brace CL,
Lee FT Jr.
Thermal ablation of lung tumors.
Surg Oncol Clin N Am.
2011; 20:369-87.
16)Malloy PC,
Grassi CJ,
Kundu S,
Gervais DA,
Miller DL,
Osnis RB,
et al.
Standards of Practice Committee with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement.
Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.
J Vasc Interv Radiol.
2009; Suppl 7: 240-9.
17)Pua BB,
Thornton RH,
Solomon SB.
Ablation of pulmonary malignancy: current status.
J Vasc Interv Radiol.
2010; Suppl 8: 223-32.
18) Department of Health.
Cancer Reform Strategy.
London: Department of Health,
2007. http://www.nao.org.uk/wp-content/uploads/2010/11/1011568.pdf.
Acceso el 10/10/2013.